A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce ...

A new study finds that popular GLP-1 drugs used to treat diabetes and obesity show new promise in fighting multiple substance use disorders.

Researchers at Washington University School of Medicine in St. Louis show in a new study that GLP-1 medications may be ...

The FDA issued warning letters to 30 telehealth companies over misleading claims about compounded versions of popular ...

Ozempic, Mounjaro and other GLP-1 drugs for diabetes can prevent the formation of new substance ​use disorders and alleviate ...

A doctor sits with Tram Mai to discuss what we should know about GLP-1 drugs and their side effects. McDonald's CEO prepares ...

GoodRx reports that GLP-1 medications will expand in use and accessibility, with new oral options and evolving insurance coverage trends.

The FDA is taking no prisoners as it continues its efforts to combat widespread GLP-1 drug compounding. | In the letters sent ...

According to the Gallup National Health and Well-Being Index, 37% of U.S. adults now report obesity, down from 39.9% three ...

People on GLP-1s had slightly higher risks of osteoporosis and gout than similar people not taking these drugs. But diet and ...

Combining GLP-1 medications with 8 healthy lifestyle habits reduced the risk of major adverse cardiovascular events, or MACE, in people with diabetes by as much as 60%, according to a study in The ...

GLP-1 drugs Ozempic, Wegovy, Mounjaro and Zepbound can help patients lose anywhere from 15% to 20% of body weight. But what ...